Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Public ClinicalTrials.gov record NCT05949593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 3, multicenter, double-masked, parallel-group, placebo-controlled, randomized, fixed-dose clinical study is designed to evaluate the efficacy and safety of tinlarebant (LBS-008) in subjects diagnosed with GA.
Study identification
- NCT ID
- NCT05949593
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 429 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2023 (Actual)
- Primary completion
- Jun 30, 2027 (Estimated)
- Completion
- Aug 31, 2027 (Estimated)
- Last update posted
- Jan 7, 2026
2023 – 2027
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Belite Study Site | Phoenix | Arizona | 85020 | — |
| Belite Study Site | Arcadia | California | 91007 | — |
| Belite Study Site | Beverly Hills | California | 90211 | — |
| Belite Study Site | Huntington Beach | California | 92467 | — |
| Belite Study Site | Los Angeles | California | 90033 | — |
| Belite Study Site | Palo Alto | California | 94303 | — |
| Belite Study Site | San Diego | California | 92093 | — |
| Belite Study Site | Lakeland | Florida | 33805 | — |
| Belite Study Site | Hagerstown | Maryland | 21740 | — |
| Belite Study Site | Saint Louis Park | Minnesota | 55416 | — |
| Belite Study Site | Westbury | New York | 11590 | — |
| Belite Study Site | Cary | North Carolina | 27511 | — |
| Belite Study Site | Durham | North Carolina | 27710 | — |
| Belite Study Site | Wake Forest | North Carolina | 27587 | — |
| Belite Study Site | Portland | Oregon | 97239 | — |
| Belite Study Site | Philadelphia | Pennsylvania | 19107 | — |
| Belite Study Site | Sewickley | Pennsylvania | 15143 | — |
| Belite Study Site | Germantown | Tennessee | 38138 | — |
| Belite Study Site | Abilene | Texas | 79606 | — |
| Belite Study Site | Dallas | Texas | 75231 | — |
| Belite Study Site | San Antonio | Texas | 78240 | — |
| Belite Study Site | Warrenton | Virginia | 20186 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05949593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05949593 live on ClinicalTrials.gov.